MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $109,866,000 | +59.4% | 3,309,206 | +39.6% | 6.94% | +36.8% |
| Q4 2018 | $68,905,000 | -9.0% | 2,370,296 | +44.0% | 5.07% | +24.3% |
| Q3 2018 | $75,731,000 | +6.1% | 1,646,330 | -16.6% | 4.08% | -48.4% |
| Q3 2017 | $71,390,000 | -15.4% | 1,973,177 | -39.6% | 7.90% | -20.6% |
| Q2 2017 | $84,432,000 | +47.7% | 3,267,487 | +9.8% | 9.95% | +66.1% |
| Q1 2017 | $57,146,000 | +47.2% | 2,976,356 | +27.8% | 5.99% | +40.5% |
| Q4 2016 | $38,823,000 | +122.0% | 2,328,932 | +174.0% | 4.26% | +153.4% |
| Q3 2016 | $17,485,000 | -11.5% | 850,000 | +67.4% | 1.68% | -42.7% |
| Q2 2014 | $19,759,000 | -66.9% | 507,682 | -70.9% | 2.94% | -66.9% |
| Q1 2014 | $59,632,000 | – | 1,744,150 | – | 8.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |